Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL)

Cancer Biology and Therapy

Volumn 3, Issue 10, 2004, Pages 989-994

  Harikrishnan, K N ^a   Bassal, Sahar ^a   Tikellis, Chris ^a   El Osta, Assam ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

B cell chronic lymphocytic leukemia; Cancer; Chromatin remodelling; DNA methyltransferases; Epigenetic; Histone methyltransferases; Methyl CpG binding proteins; Methylation

Indexed keywords

CYCLINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE; ISOENZYME; METHYL CPG BINDING PROTEIN; DNA; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; DNA BINDING PROTEIN; EUCHROMATIC HISTONE METHYLTRANSFERASE 1; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; MBD2 PROTEIN, HUMAN; MECP2 PROTEIN, HUMAN; METHYL CPG BINDING PROTEIN 2; METHYLTRANSFERASE; NONHISTONE PROTEIN; REPRESSOR PROTEIN;

ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CANCER STAGING; CHROMATIN; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME ANALYSIS; EPIGENETICS; EUKARYOTE; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARDIZATION; COMPARATIVE STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM;

B-LYMPHOCYTES; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA, NEOPLASM; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; METHYL-CPG-BINDING PROTEIN 2; METHYLTRANSFERASES; REPRESSOR PROTEINS;

EID: 21244446956     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.10.1137     Document Type: Article

References (39)

1. Galton DA, MacLennan IC. Clinical patterns in B lymphoid malignancy. Clin Haematol 1982; 11:561-87.
2. Freedman AS, Boyd AW, Bieber FR, Daley J, Rosen K, Horowitz JC, et al. Normal cellular counterparts of B cell chronic lymphocytic leukemia. Blood 1987; 70:418-27.
3. Rosenthal P, Rimm IJ, Umiel T, Griffin JD, Osathanondh R, Schlossman SF, et al. Ontogeny of human hematopoietic cells: Analysis utilizing monoclonal antibodies. J Immunol 1983; 131:232-7.
4. Caligaris-Cappio F, Gobbi M, Bofill M, Janossy G. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 1982; 155:623-8.
5. Wahlfors J, Hiltunen H, Heinonen K, Hamalainen E, Alhonen L, Janne J. Genomic hypomethylation in human chronic lymphocytic leukemia. Blood 1992; 80:2074-80.
6. Stach D, Schmitz OJ, Stilgenbauer S, Benner A, Dohner H, Wiessler M, et al. Capillary electrophoretic analysis of genomic DNA methylation levels. Nucleic Acids Res 2003; 31:E2-2.
7. El-Osta A, Wolffe AP. DNA methylation and histone deacetylation in the control of gene expression: Basic biochemistry to human development and disease. Gene Expr 2000; 9:63-75.
8. Jaenisch R, Bird A. Epigenetic regulation of gene expression: How the 1genome integrates intrinsic and environmental signals. Nat Genet 2003; 33:245-54.
9. Bestor TH. Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. Embo J 1992; 11:2611-7.
10. Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998; 19:219-220.
11. Baylin S, Bestor TH. Altered methylation patterns in cancer cell genomes: Cause or consequence? Cancer Cell 2002; 1:299-305.
12. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002; 416:552-6.
13. Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, et al. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 2001; 97:1172-9.
14. Melki JR, Warnecke P, Vincent PC, Clark SJ. Increased DNA methyltransferase expression in leukaemia. Leukemia 1998; 12:311-6.
15. Issa JP, Vertino PM, Wu J, Sazawal S, Celano P, Nelkin BD, et al. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 1993; 85:1235-40.
16. Belinsky SA, Nikula KJ, Baylin SB, Issa JP. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc Natl Acad Sci USA 1996; 93:4045-50.
17. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343:1910-6.
18. Lipsanen V, Leinonen P, Alhonen L, Janne J. Hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia. Blood 1988; 72:2042-4.
19. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82:1820-8.
20. Melki JR, Vincent PC, Brown RD, Clark SJ. Hypermethylation of E-cadherin in leukemia. Blood 2000; 95:3208-13.
21. INK4a gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of nonHodgkin's lymphomas. Blood 1998; 91:2977-84.
22. Tamaru H, Zhang X, McMillen D, Singh PB, Nakayama J, Grewal SI, et al. Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat Genet 2003; 34:75-9.
23. Wall DM, el-Osta S, Tzelepis D, Bertoncello I, Kantharidis P, Chou ST, et al. Expression of mdr1 and mrp in the normal B-cell homologue of B-cell chronic lymphocytic leukaemia. Br J Haematol 1997; 96:697-707.
24. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48:198-206.
25. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Danenberg PV, Laird PW. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res 1999; 59:2302-6.
26. Bachman KE, Park BH, Rhee I, Rajagopalan H, Herman JG, Baylin SB, et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 2003; 3:89-95.
27. Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C, et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001; 107:323-37.
28. Schneider R, Bannister AJ, Kouzarides T. Unsafe SETs: Histone lysine methyltransferases and cancer. Trends Biochem Sci 2002; 27:396-402.
29. Visser HP, Gunster MJ, Kluin-Nelemans HC, Manders EM, Raaphorst FM, Meijer CJ, et al. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol 2001; 112:950-8.
30. Billard LM, Magdinier F, Lenoir GM, Frappart L, Dante R. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland. Oncogene 2002; 21:2704-12.
31. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99:247-57.
32. Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300:455.
33. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300:489-92.
34. Fahrner JA, Eguchi S, Herman JG, Baylin SB. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res 2002; 62:7213-8.
35. Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G, et al. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res 2002; 62:6456-61.
36. Wolffe AP, Jones PL, Wade PA. DNA demethylation. Proc Natl Acad Sci USA 1999; 96:5894-6.
37. de Capoa A, Grappelli C, Febbo FR, Spano A, Niveleau A, Cafolla A, et al. Methylation levels of normal and chronic lymphocytic leukemia B lymphocytes: Computer-assisted quantitative analysis of anti-5-methylcytosine antibody binding to individual nuclei. Cytometry 1999; 36:157-9.
38. INK4a and RASSF1A in human lung cancer cell lines. Oncogene 2002; 21:4822-9.
39. Dennis K, Fan T, Geiman T, Yan Q, Muegge K. Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev 2001; 15:2940-4.